Chantal Devin
5Patents
2h-index
10Co-inventors
44Inventor score
Filing activity: May 22, 2008 → Jul 18, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10125165B2 | Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts | Emerging Cross-Sectional Technologies | 3 | Active |
| US11078234B2 | Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts | Emerging Cross-Sectional Technologies | 2 | Active |
| US11753441B2 | Solution phase synthesis of beta-turn peptidomimetic cyclic salts | Emerging Cross-Sectional Technologies | 1 | Active |
| US9243030B2 | Optically pure compounds for improved therapeutic efficiency | Human Necessities | 0 | Active |
| US12281179B2 | Solution phase synthesis of β-turn peptidomimetic cyclic salts | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.